In the leading CD19 CAR-NK trials, CRS has been rare or absent: Liu et al. (2020) and Marin et al. (2024) reported no CRS of any grade; other CAR-NK programs show only low-grade CRS. Here, CD19 is linked to congenital rubella syndrome.